CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 52 enrolled
Drug / intervention
Marketed Soft Contact lens +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02394756
NCT02394756N/ACompleted
CompareCT.gov

Investigation of Ocular Signs & Symptoms in Wearers Fitted With Contact Lenses Following Digital Device Use

Johnson & Johnson Vision Care, Inc.·interventional·Posted Mar 20, 2015·Updated Jun 19, 2018

In Brief

A clinical study evaluating Marketed Soft Contact lens, AIR OPTIX® AQUA, and 1 other intervention for Visual Performance. Completed, enrolled 52 participants across 1 site.

Detailed Summary

The objective of this study is to assess how various silicone hydrogel lenses perform when worn by subjects who are heavy digital device users.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVisual Performance
CountriesCanada
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedMar 20, 2015
Enrollment StartFeb 1, 2015
Primary CompletionSep 1, 2015
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 11.3 years ago

Interventions

Marketed Soft Contact lensdevice

Replacement schedule every 2 weeks

AIR OPTIX® AQUAdevice

Replacement schedule every 4 weeks

Biofinity®device

Replacement schedule every 4 weeks